Table of Contents
An ObGyn’s guide to aromatase inhibitors
as adjuvant therapy for breast cancer
Hear Dr. Kaunitz describe bone-protective strategies for patients on AI therapy
Skilled US imaging of the adnexae
Part 2 of 4: The non-neoplastic ovarian mass
READ THE SERIES
A new (to the US) first-line agent for heavy menstrual bleeding
Update: pelvic floor dysfunction
Examining The Evidence
At what thickness is the endometrial stripe cause for concern
in a woman who has postmenopausal bleeding?
Why you should recommend flu vaccine to "every single patient"
AAGL: Laparoscopic or vaginal hysterectomy preferred
New study reveals a link between estrogen-progestin HRT and advanced breast cancer
Sex practices driving surge in HPV-linked oral cancer
The patient-centered medical home: Is it a win-all or lose-all proposition for ObGyns?
Twitter 101 for ObGyns: Pearls, pitfalls, and potential
Comment & Controversy
Cost is a deterrent to IUD use...Want to increase IUD use? Remove the financial risk
Large prolapsed fibroid left untreated—despite surgery ...
Subscribe to OBG Management e-alert
Back to top